ConductScience.org, home

Paper15534239

Donepezil improved memory in multiple sclerosis in a randomized clinical trial.

Krupp LB and 5 others. Neurology, 2004. Cited by 187 papers, by iCite.

Cite this record

ConductScience Library. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Papers, record 15534239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15534239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Donepezil improved memory in multiple sclerosis in a randomized clinical trial.
PubMed
Journal
Neurology
PubMed
Year
2004
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
187
iCite
Relative citation ratio, by iCite
5.79
iCite
Revised in PubMed
2022-03-17
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Krupp LBL B
2Christodoulou CC
3Melville PP
4Scherl WFW F
5MacAllister WSW S
6Elkins LEL E

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cholinesterase InhibitorsMajor topic
IndansMajor topic
MemoryMajor topic
Multiple SclerosisMajor topic
Nootropic AgentsMajor topic
PiperidinesMajor topic
Adolescent
Adult
Donepezil
Double-Blind Method
Female
Follow-Up Studies
Humans
Male
Middle Aged
Treatment Outcome

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
HD38107-01NICHD NIH HHSUnited StatesPubMedPubMed
M01-RR10710-02NCRR NIH HHSUnited StatesM01RR107100PubMedNIH RePORTER
M01RR010710NIHNIH RePORTER
R01HD038107NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00315367A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory DifficultiesBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in15534232Treating cognitive deficits in multiple sclerosis: are we there yet?https://conductscience.org/library/papers/15534232PubMed
Comment in15911833Donepezil improved memory in multiple sclerosis in a randomized clinical trial.https://conductscience.org/library/papers/15911833PubMed

Download CSV of comments and corrections

Cited by64

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 187 citations.

PMIDTitleJournalYearIn PapersSource
41127289Pharmacological treatment options for cognitive dysfunction induced by multiple sclerosis: a network meta-analysis.Front Neurol2025https://conductscience.org/library/papers/41127289PubMed
38709986Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116).J Clin Oncol2024https://conductscience.org/library/papers/38709986PubMed
37508875Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review.Bioengineering (Basel)2023https://conductscience.org/library/papers/37508875PubMed
37445309Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges.J Clin Med2023https://conductscience.org/library/papers/37445309PubMed
35822102Diagnosis of coexistent neurodegenerative dementias in multiple sclerosis.Brain Commun2022https://conductscience.org/library/papers/35822102PubMed
33588903Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials.Orphanet J Rare Dis2021https://conductscience.org/library/papers/33588903PubMed
33299606Comparison of Cognitive Rehabilitation versus Donepezil Therapy on Memory Performance, Attention, Quality of Life, and Depression among Multiple Sclerosis Patients.Neurol Res Int2020https://conductscience.org/library/papers/33299606PubMed
32742613Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial.Int J Prev Med2020https://conductscience.org/library/papers/32742613PubMed
32361940Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review.CNS Drugs2020https://conductscience.org/library/papers/32361940PubMed
31659498Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers.EJNMMI Radiopharm Chem2019https://conductscience.org/library/papers/31659498PubMed
31467038Glutamine antagonism attenuates physical and cognitive deficits in a model of MS.Neurol Neuroimmunol Neuroinflamm2019https://conductscience.org/library/papers/31467038PubMed
30893874Assessment and Impact of Cognitive Impairment in Multiple Sclerosis: An Overview.Biomedicines2019https://conductscience.org/library/papers/30893874PubMed
30303036Recommendations for cognitive screening and management in multiple sclerosis care.Mult Scler2018https://conductscience.org/library/papers/30303036PubMed
29770225Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: Results of the WFU CCOP research base protocol 91105.Neurooncol Pract2018https://conductscience.org/library/papers/29770225PubMed
29356970Cognitive phenotypes in multiple sclerosis.J Neurol2018https://conductscience.org/library/papers/29356970PubMed
29119933Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis.Curr Neuropharmacol2018https://conductscience.org/library/papers/29119933PubMed
29079868[New aspects of symptomatic MS treatment: Part 6 - cognitive dysfunction and rehabilitation].Nervenarzt2018https://conductscience.org/library/papers/29079868PubMed
28374837Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients.Sci Rep2017https://conductscience.org/library/papers/28374837PubMed
28360700The Effects of Cognitive Rehabilitation on Relapsing Remitting Multiple Sclerosis Patients.Noro Psikiyatr Ars2015https://conductscience.org/library/papers/28360700PubMed
28360664A Case of Cortical Multiple Sclerosis.Noro Psikiyatr Ars2014https://conductscience.org/library/papers/28360664PubMed

See all 64 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15534239

GET https://conductscience.org/api/papers/v1/15534239/cited_by?page=2